Clinical Study on the Treatment of Senile Weakness Syndrome of Kidney Essence Deficiency Type with Dihuang Yinzi

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072582

Enrollment

Unknown

Registered

2023-06-19

Start date

2023-06-19

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frailty

Interventions

control group:Basic treatment and care of Western medicine

treatment group:traditional Chinese medicine+Basic treatment and care of Western medicine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Diagnosed as frailty syndrome through the frailty screening scale (The "FRAIL" Scale); ? Conforming to the syndrome of elderly frailty and kidney essence deficiency in traditional Chinese medicine; ? Patients aged between 60 and 90, regardless of gender; ? Conscious, without physical disabilities, able to cooperate; ? Voluntarily accept clinical trials and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Long term bed rest; ? Patients with severe heart, brain, liver, kidney, hematopoietic, and immune system diseases, as well as those with implanted cardiac pacemakers; ? Patients with diabetes and poor blood glucose control (HbA1c>8.0%); ? Acute systemic infectious diseases; ? Severe osteoarthritis; ? Patients who have participated in other clinical trials within the past month.

Design outcomes

Primary

Measure	Time frame
SPECT cerebral blood flow perfusion imaging;EFS;	—

Secondary

Measure	Time frame
blood fat;Vitamin testing;Bone metabolism testing;Interleukin detection;TFN;RBP;SOD;TP,ALB;	—

Countries

China

Contacts

Public ContactXuehua Cheng

Huadong Hospital Affiliated to Fudan University

396305322@qq.com+86 136 4195 3369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026